Fresenius Kabi introduced Fentanyl Citrate Injection, USP 50 mcg per 1 mL in its Simplist ready-to-administer prefilled syringe, the only 1 mL presentation currently available in the U.S. The 50 mcg per 1 mL prefilled syringe is designed to support initiatives at hospitals nationwide to reduce waste and diversion and help ensure safe delivery of the medication by eliminating steps where errors can occur.

Simplist Fentanyl ready-to-administer prefilled syringes come in Fresenius Kabi’s MicroVault packaging system that also supports secure dispensing of narcotics and reduces the opportunity for diversion. Because the syringes require no assembly, they streamline point-of-care preparation. The presentation is designed to reduce the potential for product waste and to make it easier for health care professionals to dispense the prescribed dose.

“The introduction of an exclusive smaller-dose fentanyl injection is an important expansion of our Simplist ready-to-administer prefilled syringe portfolio in line with our commitment to the secure dispensing of controlled substances for the safe delivery of drugs to patients,” said John Ducker, president and CEO of Fresenius Kabi USA. “We are proud to design, develop and introduce products and labeling that support the safe dispensing of controlled substances, and all products.”

Fresenius Kabi’s Simplist prefilled syringes were associated with an error rate that was four times lower when compared to traditional medication administration practice, according to a study published in the Journal of Patient Safety in 2018. The Simplist Fentanyl prefilled syringe is manufacturer prepared in the U.S., with a 24-month shelf life, and is a single-unit dose, supporting best practices for medication administration.